Figure 4.
NEO2734 is more active than birabresib, CBP30, and NEO1132 in DLBCL cell lines. IC50 and IC90 values calculated for DLBCL cell lines exposed for 72 hours to the compounds. (A) IC50 value comparison between NEO2734, NEO1132, birabresib, and CBP30. (B) IC90 value comparison between NEO2734 and birabresib. (C) AUC comparison between NEO2734 and birabresib. Each point represents 1 cell line with the respective IC50/IC90/AUC. The line in the middle of the boxes represents the median IC50/IC90/AUC with 95% of CI. IC90 values >20 μM were arbitrarily set as 30 μM. Statistics were calculated with the Mann-Whitney U test. *P < .05, **P < .01, ****P < .0001. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

NEO2734 is more active than birabresib, CBP30, and NEO1132 in DLBCL cell lines. IC50 and IC90 values calculated for DLBCL cell lines exposed for 72 hours to the compounds. (A) IC50 value comparison between NEO2734, NEO1132, birabresib, and CBP30. (B) IC90 value comparison between NEO2734 and birabresib. (C) AUC comparison between NEO2734 and birabresib. Each point represents 1 cell line with the respective IC50/IC90/AUC. The line in the middle of the boxes represents the median IC50/IC90/AUC with 95% of CI. IC90 values >20 μM were arbitrarily set as 30 μM. Statistics were calculated with the Mann-Whitney U test. *P < .05, **P < .01, ****P < .0001. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

Close Modal

or Create an Account

Close Modal
Close Modal